Compounded Tirzepatide Cost: What You Actually Pay per Month

Compounded tirzepatide from a US telehealth program usually costs between $198 and $299 a month. Across the 368 programs we track that publish a tirzepatide price (counted October 2026), the median is about $249 a month and the lower quartile is around $198. The cheapest publishing a genuinely flat, month-to-month rate with no plan term is $129. Most advertised figures are starting prices: 262 of the 368 begin with the word "From."

That last number matters more than the median. A "from" price is usually the starting dose or the longest prepay plan. Your real monthly cost depends on the dose you end up on and how long you commit. This page explains how to read the price. Our cheapest tirzepatide ranking lists every program by price.

Compounded tirzepatide prices at a glance

Each program is counted once, at the lowest monthly tirzepatide figure its own website publishes. "Flagged flat" means we read the seller's terms and the price stays the same as the dose goes up, with no first-month promo. The rest carry a condition to watch, such as a dose ladder, a prepay term, a membership fee or an intro rate.

Two things stand out:

• Only 52 of 368 programs (about 14%) are flagged flat. Most published tirzepatide prices change once you sign up, either as your dose rises or when an intro period ends.
• The cheapest prices are mostly conditional. Of the 49 programs listing $149 or less, 8 are flagged flat. The lowest figures, starting at $69, come with a required membership fee, a starting-dose-only price, a first-month price or a multi-month plan.

The cheapest flat prices we found

These programs publish a flat month-to-month tirzepatide price, counted October 2026. Read each review for the conditions before you pay.

Flagged flat does not mean cheapest overall. It means the number you see is the number you keep paying. A $129 flat price can cost less over six months than a $99 starting price that climbs to $299 at your maintenance dose.

Why the price climbs with dose, and who charges flat

Tirzepatide is titrated: you start at a low dose and step up every few weeks. Compounded tirzepatide is priced by the milligram, so a program that charges by dose may bill your maintenance month at two or three times the starting price. That is why 262 published prices start with "From." In most cases, that word means "at the lowest dose."

Programs price in one of three ways:

1. 1Flat at every dose. One price from your first month to your last. These programs carry the higher starting numbers, because the price already includes the maintenance doses.
2. 2Dose-tiered. The advertised price applies to the starting dose. Ask for the price at the dose you expect to reach, not the dose you start on.
3. 3Term-tiered. The lowest rate requires prepaying 3, 6 or 12 months. The month-to-month rate is higher, and a prepaid plan is often non-refundable once the medication ships.

Some programs combine dose tiers and term tiers. Our teaser-rate trap guide covers the common patterns: first-month prices, separate membership bills, and "monthly" plans billed every 21 or 28 days.

What the monthly price includes

Two programs both listed at $199 can produce very different bills. Before you compare, check:

• The clinician visit. Some prices include the medical review. Others charge a separate consult or membership fee every month or every year.
• Shipping. Compounded tirzepatide ships cold. Some prices include shipping, and others add it at checkout.
• Supplies. Syringes and alcohol swabs are sometimes included and sometimes extra.
• How often you are billed. Some "monthly" plans bill every 28 days, which adds up to 13 bills a year instead of 12.
• What happens if you stop. Prepaid plans often refund nothing once the medication ships.

Our table above counts the medication price each seller publishes. Where a program bills a separate required fee, we note it in that program's review.

Compounded tirzepatide vs Zepbound per month

Eli Lilly sells Zepbound (brand-name tirzepatide) directly to self-pay patients. The single-patient-use KwikPen costs $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. A purchase offer cuts 7.5 mg and higher to $449, but only if you refill within 45 days of your previous fill¹. Lilly also lists Zepbound single-dose vials from $299 a month¹.

At the median, compounded tirzepatide costs about $200 a month less than Zepbound with the purchase offer. The gap is real, but the two products are not the same thing:

• Zepbound is FDA-approved. "Compounded drugs are not FDA-approved," and the FDA "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed"².
• The FDA says compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug," and it reports more than 730 adverse event reports tied to compounded tirzepatide as of May 31, 2026³.

Our Zepbound cost guide covers the full brand price ladder and the 45-day rule. For a side-by-side comparison of compounded and brand-name prices, see compounded vs brand-name GLP-1 cost.

Why the rules affect what you pay

Compounded tirzepatide is sold during an FDA crackdown, and the rules can change which programs stay open and at what price.

The shortage is over. The FDA declared the tirzepatide injection shortage resolved. State-licensed 503A pharmacies had until February 18, 2025, and 503B outsourcing facilities had until March 19, 2025, to stop making versions that are "essentially copies" of the approved drug⁴. Since then, a compounded version is supposed to contain a change that a prescriber documents as making a significant difference for a specific patient⁴.

503A and 503B are held to different standards. State boards of pharmacy oversee 503A pharmacies, which are not subject to current good manufacturing practice (CGMP) requirements. 503B outsourcing facilities are overseen and inspected by the FDA and must follow CGMP².

The FDA has proposed closing the 503B route. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound them from bulk drug substances⁵. The comment docket was open through June 29, 2026⁵. No final decision has been announced. If one comes, programs supplied by 503B facilities could change pharmacies or prices quickly.

Additives may not protect a product. Many programs sell tirzepatide combined with niacinamide, vitamin B6 or glycine. On September 18, 2026, the FDA issued a warning letter to a compounding pharmacy in Houston, Texas. The letter cited tirzepatide/niacinamide products made "regularly and in inordinate amounts" and called the differences from the approved drug "pretextual"⁶. If a program charges more for an additive blend, you are not buying regulatory protection.

How to check a price before you pay

1. 1Ask for the price at your maintenance dose, not the starting dose. If the program will not tell you in writing, treat the advertised price as an intro rate.
2. 2Ask for the month-to-month price. Divide any prepay plan by its true number of months and check the refund terms.
3. 3Add up every bill, including membership, consult and shipping fees.
4. 4Check how often you are billed. Count the number of charges per year.
5. 5Ask for the pharmacy's name. Then check whether it is a 503A or 503B facility and look up its license. Our guide on how to verify a compounding pharmacy walks through each step, and is cheap compounded GLP-1 safe? explains what a low price can and cannot tell you.

To see every program's price in one sorted list, go to the cheapest tirzepatide ranking. To compare programs on more than price, see tirzepatide programs ranked by value.